Literature DB >> 19697064

Role of the extracellular matrix in lymphocyte migration.

Eva Korpos1, Chuan Wu, Jian Song, Rupert Hallmann, Lydia Sorokin.   

Abstract

The extracellular matrix (ECM) exists in various biochemical and structural forms that can act either as a barrier to migrating leukocytes, in the case of basement membranes, or provide a physical scaffold supporting or guiding migration (interstitial matrix). This review focuses on basement membranes and our current knowledge of the way that leukocytes transmigrate this protein barrier, with emphasis on T lymphocytes. Recent data suggest that the classical concept of cell-matrix adhesion requires revision with respect to leukocyte-ECM interactions. Whereas specific receptors may be required for leukocyte recognition of ECM molecules or three-dimensional structural domains, the role of adhesion in migration as perceived from the traditional studies of adherent cell-ECM interactions is less clear. Further, the indirect effects of ECM such as the binding and presentation of cytokines or chemotactic factors may more profoundly influence the directed migration of normally non-adherent leukocytes than the migration of adherent cells such as epithelial cells or fibroblasts. Proteases (in particular matrix metalloproteinases) released at sites of inflammation can selectively process ECM, cell surface molecules or soluble factors, which may result in the release of bioactive fragments that can function as chemoattractants for different leukocyte subsets or may modulate the activity/function of resident mesenchymal and immune cells. Current findings suggest that different leukocyte types employ different mechanisms to migrate across or through the ECM; this might be determined by the composition and organization of the ECM itself.

Mesh:

Substances:

Year:  2009        PMID: 19697064     DOI: 10.1007/s00441-009-0853-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  26 in total

Review 1.  Fragile privileges: autoimmunity in brain and eye.

Authors:  Hartmut Wekerle; De-ming Sun
Journal:  Acta Pharmacol Sin       Date:  2010-09       Impact factor: 6.150

Review 2.  Immunometabolism in the development of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Immunol Rev       Date:  2020-01-27       Impact factor: 12.988

3.  Distribution of laminin β2, collagen type IV, fibronectin and MMP-9 in ovaries of the teleost fish.

Authors:  Ralph Thomé; Hélio Batista dos Santos; Yoshimi Sato; Elizete Rizzo; Nilo Bazzoli
Journal:  J Mol Histol       Date:  2010-08-04       Impact factor: 2.611

4.  Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair.

Authors:  Ping M Wang; Diane L Kachel; Mark F Cesta; William J Martin
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 5.  Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.

Authors:  Vanessa H Brait; Thiruma V Arumugam; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-01       Impact factor: 6.200

6.  Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.

Authors:  Adam J Booth; Sherri C Wood; Ashley M Cornett; Alyssa A Dreffs; Guanyi Lu; Andrés F Muro; Eric S White; D Keith Bishop
Journal:  J Pathol       Date:  2012-01-04       Impact factor: 7.996

7.  Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Paul L Bollyky; Gerald T Nepom; Thomas N Wight
Journal:  Matrix Biol       Date:  2011-11-20       Impact factor: 11.583

8.  The proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph gland.

Authors:  Melina Grigorian; Ting Liu; Utpal Banerjee; Volker Hartenstein
Journal:  Dev Biol       Date:  2013-03-16       Impact factor: 3.582

9.  Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice.

Authors:  Sheetal Bodhankar; Yingxin Chen; Arthur A Vandenbark; Stephanie J Murphy; Halina Offner
Journal:  Metab Brain Dis       Date:  2013-12-28       Impact factor: 3.584

10.  Macrophage migration and invasion is regulated by MMP10 expression.

Authors:  Megan Y Murray; Timothy P Birkland; Jonathan D Howe; Andrew D Rowan; Mark Fidock; William C Parks; Jelena Gavrilovic
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.